Market Overview

UPDATE: Baird Downgrades Align Technology on Valuation Call

Related ALGN
Medical Device Co. Align Technology Has Clear Upside, Says Leerink
Trial Date Set For Traders Accused Of $100 Million Hacking Scheme
Align Technology to Announce Third Quarter 2015 Results on October 22, 2015 (GuruFocus)

In a report published Friday, Baird Equity Research analyst Jeff D. Johnson downgraded the rating on Align Technology (NASDAQ: ALGN) from Outperform to Neutral, but reiterated the $49.00 price target.

In the report, Baird Equity Research noted, “Downgrading ALGN to Neutral is not meant to be a call on the company's 3Q, especially as our intra-quarter checks have been generally positive and we still expect modest upside to our/Street's projections this quarter. Further, we continue to like that management has seemingly gone on the offensive recently in both the high- (G4/SmartTrack) and low-acuity (Express 5/Realine) segments of orthodontics.”

Align Technology closed on Thursday at $47.87.

Latest Ratings for ALGN

Jul 2015Stifel NicolausMaintainsBuy
Apr 2015Morgan StanleyUpgradesEqual-weightOverweight
Jan 2015JMP SecuritiesDowngradesMarket OutperformMarket Perform

View More Analyst Ratings for ALGN
View the Latest Analyst Ratings

Posted-In: Baird Equity Research Jeff D. JohnsonAnalyst Color Downgrades Analyst Ratings


Related Articles (ALGN)

View Comments and Join the Discussion!

Get Benzinga's Newsletters